Main clinical and exercise data of patients who were and who were not clinically followed up
| Follow up (n = 375) | No follow up (n = 278) | p Value | |
|---|---|---|---|
| Data are mean (SD) or number (%). | |||
| Age (years) | 60.2 (9) | 59.8 (9) | 0.60 |
| Men | 305 (81.3%) | 224 (80.6%) | 0.81 |
| Diabetes | 52 (13.9%) | 37 (17.2%) | 0.59 |
| Previous MI | 181 (48.3%) | 157 (56.5%) | 0.04 |
| Unstable angina | 48 (12.5%) | 48 (17.3%) | 0.27 |
| LVEF (%) | 51.3 (8) | 52.4 (9) | 0.10 |
| PCI | 53 (14.1%) | 30 (10.8%) | 0.37 |
| CABG | 31 (8.3%) | 18 (6.5%) | 0.39 |
| Coronary angiography | |||
| 0 vessel CAD | 54 (14.4%) | 50 (18%) | 0.41 |
| 1 vessel CAD | 105 (28%) | 64 (23%) | |
| 2 vessel CAD | 115 (30.7%) | 87 (31%) | |
| 3 vessel CAD | 101 (26.9%) | 77 (27.8%) | |
| β Blockers | 76 (23.5%) | 60 (26.2%) | 0.46 |
| Calcium antagonists | 122 (32.5%) | 120 (43.1%) | 0.35 |
| Nitrates | 144 (38.4%) | 95 (34.2%) | 0.36 |
| Exercise results | |||
| Peak heart rate (beats/min) | 124 (22) | 122 (23) | 0.31 |
| Peak systolic blood pressure (mm Hg) | 173 (31) | 172 (31) | 0.71 |
| Peak rate–pressure product (beats/min × mm Hg) | 21768 (6066) | 21287 (6018) | 0.32 |
| METs | 6.58 (3.0) | 6.60 (2.9) | 0.55 |
| Maximum ST segment depression (mm) | 1.87 (0.8) | 1.83 (0.7) | 0.49 |
| Angina | 138 (37%) | 92 (34%) | 0.73 |